Jonathan Brudvig | Medical Director, US Fabry
Amicus Therapeutics

Jon Brudvig, PhD, is Senior Director and US Regional Medical Lead for Fabry Disease at Amicus Therapeutics, where he leads medical strategy across Medical Affairs, field medical, and cross-functional teams. His work focuses on advancing understanding of Fabry disease biology, advancing evidence generation, and supporting better outcomes for people living with rare diseases. Jon brings experience across R&D and Medical Affairs, having led programs from early discovery through clinical development. His expertise includes translational science, biomarker development, rare disease strategy, and cross-functional evidence generation efforts. He has authored numerous scientific publications, contributed to multiple therapeutic programs, and is an inventor on several patents related to rare disease therapeutics.